Bank of America Corp DE Sells 22,425 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Bank of America Corp DE trimmed its holdings in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 8.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 256,518 shares of the company’s stock after selling 22,425 shares during the period. Bank of America Corp DE owned approximately 5.29% of SPDR S&P Pharmaceuticals ETF worth $11,028,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. AlphaMark Advisors LLC boosted its holdings in shares of SPDR S&P Pharmaceuticals ETF by 6.7% during the 4th quarter. AlphaMark Advisors LLC now owns 6,640 shares of the company’s stock worth $285,000 after buying an additional 415 shares in the last quarter. Jones Financial Companies Lllp boosted its holdings in shares of SPDR S&P Pharmaceuticals ETF by 146.4% during the 4th quarter. Jones Financial Companies Lllp now owns 993 shares of the company’s stock worth $43,000 after buying an additional 590 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of SPDR S&P Pharmaceuticals ETF by 36.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,443 shares of the company’s stock worth $197,000 after buying an additional 1,182 shares in the last quarter. US Bancorp DE bought a new position in shares of SPDR S&P Pharmaceuticals ETF during the 4th quarter worth approximately $96,000. Finally, Beacon Pointe Advisors LLC bought a new position in shares of SPDR S&P Pharmaceuticals ETF during the 4th quarter worth approximately $211,000.

SPDR S&P Pharmaceuticals ETF Stock Performance

SPDR S&P Pharmaceuticals ETF stock opened at $39.87 on Friday. The stock has a market capitalization of $137.55 million, a price-to-earnings ratio of 14.61 and a beta of 0.61. SPDR S&P Pharmaceuticals ETF has a 52-week low of $35.22 and a 52-week high of $48.76. The stock’s 50 day moving average price is $40.20 and its two-hundred day moving average price is $43.13.

About SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.